U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 8

1.
Fig. 4

Fig. 4. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

Non-clustered miRNAs with stronger expression in thymic carcinomas than in type A thymomas

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.
2.
Fig. 5

Fig. 5. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

Non-clustered miRNAs with lower expression in thymic carcinomas than in type A thymomas

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.
3.
Fig. 7

Fig. 7. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

PD-L1 protein expression in type A and B3 thymomas and thymic carcinomas

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.
4.
Fig. 6

Fig. 6. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

PDGFRA protein expression in type A and B3 thymomas and thymic carcinomas

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.
5.
Fig. 8

Fig. 8. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

p16INK4A protein expression in type A and B3 thymomas and thymic carcinomas

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.
6.
Fig. 1

Fig. 1. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

Heatmap of all miRNA transcripts differentially expressed in type A thymomas and thymic carcinomas at a false discovery rate p-value < 0.05

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.
7.
Fig. 3

Fig. 3. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

Heatmap showing different expression of C14MC miRNA cluster members in type A thymomas and thymic carcinomas at a false discovery rate p-value < 0.05

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.
8.
Fig. 2

Fig. 2. From: Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.

Heatmap showing high C19MC miRNA cluster expression in four of five type A thymomas, but virtually no expression in thymic carcinomas at a false discovery rate p-value < 0.0005

Franz Enkner, et al. Pathol Oncol Res. 2017;23(3):551-564.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center